(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.
The three biggest winners today are Youngevity International, StoneCo, and SNDL Inc..
| Rank | Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|---|
| 1 | Youngevity International (YGYI) | 0.00 | 14.29% | 2023-11-12 19:46:05 |
| 2 | StoneCo (STNE) | 12.05 | 12.36% | 2023-11-13 12:17:15 |
| 3 | SNDL Inc. (SNDL) | 1.59 | 11.19% | 2023-11-13 12:17:13 |
| 4 | FibroGen (FGEN) | 0.41 | 8.66% | 2023-11-13 12:12:15 |
| 5 | Insulet (PODD) | 166.37 | 7.26% | 2023-11-13 12:14:17 |
| 6 | DouYu (DOYU) | 0.92 | 6.91% | 2023-11-13 12:16:13 |
| 7 | Groupon (GRPN) | 9.43 | 6.86% | 2023-11-13 12:12:46 |
| 8 | Li Auto (LI) | 39.26 | 6.22% | 2023-11-13 12:16:31 |
| 9 | Beyond Air (XAIR) | 2.05 | 5.67% | 2023-11-12 19:10:05 |
| 10 | Virgin Galactic (SPCE) | 1.89 | 5.58% | 2023-11-13 13:00:38 |
The three biggest losers today are NASDAQ TEST STOCK, Aspen Group, and Kodak.
| Rank | Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|---|
| 1 | NASDAQ TEST STOCK (ZVZZT) | 15.48 | -75.14% | 2023-11-12 22:41:05 |
| 2 | Aspen Group (ASPU) | 0.15 | -9.49% | 2023-11-13 12:15:45 |
| 3 | Kodak (KODK) | 3.47 | -8.44% | 2023-11-13 12:56:22 |
| 4 | BP Prudhoe Bay Royalty Trust (BPT) | 3.26 | -7.65% | 2023-11-13 15:07:05 |
| 5 | Xcel Brands (XELB) | 0.86 | -7.63% | 2023-11-12 19:14:05 |
| 6 | Everbridge (EVBG) | 19.53 | -6.67% | 2023-11-13 12:51:37 |
| 7 | Xeris Pharmaceuticals (XERS) | 1.68 | -6.65% | 2023-11-12 19:15:06 |
| 8 | Beyond Meat (BYND) | 6.45 | -6.58% | 2023-11-13 12:15:55 |
| 9 | Yield10 Bioscience (YTEN) | 0.22 | -5.46% | 2023-11-12 21:07:05 |
| 10 | Buenaventura Mining Company (BVN) | 8.44 | -5.38% | 2023-11-13 16:23:06 |
Winners today
1. Youngevity International (YGYI) – 14.29%
Youngevity International, Inc. develops and distributes health and nutrition related products and services in the United States and internationally. It operates in three segments: Direct Selling, Commercial Coffee, and Commercial Hemp. The company offers nutritional supplements, gourmet coffee, weight management products, skincare and cosmetics, health and wellness, packaged foods, lifestyle products, pet care, digital products, telecare health services, apparel and fashion accessories, and business lending products. It also produces and sells coffee products under the Café La Rica, Café Alma, Josie's Java House, Javalution Urban Grind, Javalution Daily Grind, and Javalution Royal Roast brands; and produces and markets a line of coffees under the JavaFit brand directly to consumers. In addition, it offers cannabidiol oils from hemp stock. The company sells coffee and equipment to wellness and retirement communities, and various cruise lines and coffee service operators, as well as through distribution network. Youngevity International, Inc. also markets its products through a range of consumer Websites, such as youngevity.com; ygyi.com; heritagemakers.com; hempfx.com; clrroasters.com; cafelarica.com; javalution.com. The company was formerly known as AL International, Inc. and changed its name to Youngevity International, Inc. in July 2013. Youngevity International, Inc. was founded in 1996 and is headquartered in Chula Vista, California.
NASDAQ ended the session with Youngevity International jumping 14.29% to $0.00 on Tuesday while NASDAQ fell 0.22% to $13,767.74.
Earnings Per Share
As for profitability, Youngevity International has a trailing twelve months EPS of $-1.61.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -126.78%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 1.9%, now sitting on 137.18M for the twelve trailing months.
More news about Youngevity International.
2. StoneCo (STNE) – 12.36%
StoneCo Ltd. provides financial technology and software solutions to merchants and integrated partners to conduct electronic commerce across in-store, online, and mobile channels in Brazil. It distributes its solutions, principally through proprietary Stone Hubs, which offer hyper-local sales and services; and sells solutions to brick-and-mortar and digital merchants through sales team. The company served approximately 2.6 million clients primarily small-and-medium-sized businesses; and marketplaces, e-commerce platforms, and integrated software vendors. StoneCo Ltd. was founded in 2000 and is headquartered in George Town, the Cayman Islands.
NASDAQ ended the session with StoneCo jumping 12.36% to $12.05 on Tuesday, following the last session’s upward trend. NASDAQ dropped 0.22% to $13,767.74, following the last session’s upward trend on what was a somewhat bearish trend trading session today.
Earnings Per Share
As for profitability, StoneCo has a trailing twelve months EPS of $0.5.
PE Ratio
StoneCo has a trailing twelve months price to earnings ratio of 24.09. Meaning, the purchaser of the share is investing $24.09 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.13%.
Yearly Top and Bottom Value
StoneCo’s stock is valued at $12.05 at 01:32 EST, way under its 52-week high of $14.83 and way higher than its 52-week low of $8.09.
Volatility
StoneCo’s last week, last month’s, and last quarter’s current intraday variation average was 0.08%, 0.51%, and 2.01%.
StoneCo’s highest amplitude of average volatility was 2.01% (last week), 1.80% (last month), and 2.01% (last quarter).
Volume
Today’s last reported volume for StoneCo is 11836000 which is 159.11% above its average volume of 4567900.
Revenue Growth
Year-on-year quarterly revenue growth grew by 28.4%, now sitting on 10.57B for the twelve trailing months.
More news about StoneCo.
3. SNDL Inc. (SNDL) – 11.19%
SNDL Inc. engages in the production, distribution, and sale of cannabis products in Canada. The company operates through four segments: Liquor Retail, Cannabis Retail, Cannabis Operations, and Investments. It engages in the cultivation, distribution, and sale of cannabis for the adult-use and medical markets; sells wines, beers, and spirits through wholly owned liquor stores; and private sale of recreational cannabis through wholly owned and franchised retail cannabis stores. The company also produces and distributes inhalable products, such as flower, pre-rolls, and vapes. It offers its products under the Top Leaf, Sundial Cannabis, Palmetto, and Grasslands brands. The company was formerly known as Sundial Growers Inc. and changed its name to SNDL Inc. in July 2022. SNDL Inc. was incorporated in 2006 and is headquartered in Calgary, Canada.
NASDAQ ended the session with SNDL Inc. jumping 11.19% to $1.59 on Tuesday while NASDAQ dropped 0.22% to $13,767.74.
Earnings Per Share
As for profitability, SNDL Inc. has a trailing twelve months EPS of $-0.87.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -22.42%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 9.3%, now sitting on 917.87M for the twelve trailing months.
Volatility
SNDL Inc.’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.24%, a negative 0.44%, and a positive 3.98%.
SNDL Inc.’s highest amplitude of average volatility was 3.72% (last week), 3.40% (last month), and 3.98% (last quarter).
More news about SNDL Inc..
4. FibroGen (FGEN) – 8.66%
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. Its lead product candidates are Pamrevlumab, a human monoclonal antibody targeting connective tissue growth factor that is in Phase III clinical development for the treatment of idiopathic pulmonary fibrosis, pancreatic cancer, and Duchenne muscular dystrophy; and Roxadustat, an oral small molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase activity, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in China, Europe, Japan, and other countries, as well as in Phase III clinical development for anemia related with myelodysplastic syndromes. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. FibroGen, Inc. was incorporated in 1993 and is headquartered in San Francisco, California.
NASDAQ ended the session with FibroGen rising 8.66% to $0.41 on Tuesday, after five consecutive sessions in a row of losses. NASDAQ fell 0.22% to $13,767.74, following the last session’s upward trend on what was a somewhat negative trend exchanging session today.
Earnings Per Share
As for profitability, FibroGen has a trailing twelve months EPS of $-3.06.
Volatility
FibroGen’s last week, last month’s, and last quarter’s current intraday variation average was a negative 10.45%, a negative 2.57%, and a positive 6.81%.
FibroGen’s highest amplitude of average volatility was 10.45% (last week), 7.51% (last month), and 6.81% (last quarter).
Sales Growth
FibroGen’s sales growth is 134.1% for the ongoing quarter and 13.7% for the next.
More news about FibroGen.
5. Insulet (PODD) – 7.26%
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
NASDAQ ended the session with Insulet rising 7.26% to $166.37 on Tuesday while NASDAQ fell 0.22% to $13,767.74.
Earnings Per Share
As for profitability, Insulet has a trailing twelve months EPS of $1.72.
PE Ratio
Insulet has a trailing twelve months price to earnings ratio of 96.72. Meaning, the purchaser of the share is investing $96.72 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.18%.
Volatility
Insulet’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.63%, a positive 0.85%, and a positive 2.78%.
Insulet’s highest amplitude of average volatility was 2.28% (last week), 2.88% (last month), and 2.78% (last quarter).
Yearly Top and Bottom Value
Insulet’s stock is valued at $166.37 at 01:32 EST, way below its 52-week high of $335.91 and way above its 52-week low of $125.82.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Jan 1, 1970, the estimated forward annual dividend yield is 0.68%.
More news about Insulet.
6. DouYu (DOYU) – 6.91%
DouYu International Holdings Limited, together with its subsidiaries, operates a platform on PC and mobile apps that provides interactive games and entertainment live streaming services in the People's Republic of China. Its platform connects game developers and publishers, professional eSports teams or players and eSports tournament organizers, advertisers, and viewers. The company also sponsors professional players and teams, and organizes eSports tournaments. In addition, it streams other content to include a spectrum of live streaming entertainment options, such as talent shows, music, outdoor, and travel. Further, the company records and offers video clips to allow users to watch replays of selective live streaming content. DouYu International Holdings Limited was founded in 2014 and is headquartered in Wuhan, the People's Republic of China.
NASDAQ ended the session with DouYu jumping 6.91% to $0.92 on Tuesday while NASDAQ fell 0.22% to $13,767.74.
Earnings Per Share
As for profitability, DouYu has a trailing twelve months EPS of $0.03.
PE Ratio
DouYu has a trailing twelve months price to earnings ratio of 30.79. Meaning, the purchaser of the share is investing $30.79 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 0.86%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, DouYu’s stock is considered to be oversold (<=20).
Revenue Growth
Year-on-year quarterly revenue growth declined by 24.1%, now sitting on 6.35B for the twelve trailing months.
More news about DouYu.
7. Groupon (GRPN) – 6.86%
Groupon, Inc., together with its subsidiaries, operates a marketplace that connects consumers to merchants. It operates in two segments, North America and International. The company sells goods or services on behalf of third-party merchants; and first-party goods inventory. It serves customers through its mobile applications and websites. The company was formerly known as ThePoint.com, Inc. and changed its name to Groupon, Inc. in October 2008. Groupon, Inc. was incorporated in 2008 and is headquartered in Chicago, Illinois.
NASDAQ ended the session with Groupon jumping 6.86% to $9.43 on Tuesday, after four consecutive sessions in a row of losses. NASDAQ slid 0.22% to $13,767.74, following the last session’s upward trend on what was a somewhat down trend trading session today.
Earnings Per Share
As for profitability, Groupon has a trailing twelve months EPS of $-5.03.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -567.07%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 12.4%, now sitting on 525.35M for the twelve trailing months.
More news about Groupon.
8. Li Auto (LI) – 6.22%
Li Auto Inc., through its subsidiaries, designs, develops, manufactures, and sells new energy vehicles in the People's Republic of China. The company provides Li ONE and Li L series smart electric vehicles. It also offers sales and after sales management, and technology development and corporate management services, as well as purchases manufacturing equipment. The company offers its products through online and offline channels. The company was formerly known as Leading Ideal Inc. and changed its name to Li Auto Inc. in July 2020. Li Auto Inc. was founded in 2015 and is headquartered in Beijing, the People's Republic of China.
NASDAQ ended the session with Li Auto jumping 6.22% to $39.26 on Tuesday while NASDAQ slid 0.22% to $13,767.74.
Earnings Per Share
As for profitability, Li Auto has a trailing twelve months EPS of $0.23.
PE Ratio
Li Auto has a trailing twelve months price to earnings ratio of 170.7. Meaning, the purchaser of the share is investing $170.7 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.06%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Li Auto’s EBITDA is 9.64.
More news about Li Auto.
9. Beyond Air (XAIR) – 5.67%
Beyond Air, Inc., a clinical-stage medical device and biopharmaceutical company, develops inhaled nitric oxide (NO) to treat respiratory infections, and gaseous NO to treat solid tumors. The company is developing LungFit system, a NO generator and delivery system, which is in clinical trials for the treatment of lung infections, persistent pulmonary hypertension of the newborn, severe acute respiratory syndrome coronavirus 2, bronchiolitis, and nontuberculous mycobacteria.The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. The company is based in Garden City, New York.
NASDAQ ended the session with Beyond Air rising 5.67% to $2.05 on Tuesday, following the last session’s upward trend. NASDAQ dropped 0.22% to $13,767.74, following the last session’s upward trend on what was a somewhat down trend trading session today.
Earnings Per Share
As for profitability, Beyond Air has a trailing twelve months EPS of $-1.94.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -113.68%.
More news about Beyond Air.
10. Virgin Galactic (SPCE) – 5.58%
Virgin Galactic Holdings, Inc. focuses on the development, manufacture, and operation of spaceships and related technologies for conducting commercial human spaceflight and flying commercial research and development payloads into space. It is also involved in the ground and flight testing, and post-flight maintenance of its spaceflight system vehicles. The company serves private individuals, researchers, and government agencies. Virgin Galactic Holdings, Inc. was founded in 2017 is headquartered in Las Cruces, New Mexico.
NYSE ended the session with Virgin Galactic rising 5.58% to $1.89 on Tuesday, following the last session’s downward trend. NYSE jumped 0.07% to $15,399.82, following the last session’s upward trend on what was a somewhat positive trend trading session today.
Earnings Per Share
As for profitability, Virgin Galactic has a trailing twelve months EPS of $-1.81.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -90.56%.
Sales Growth
Virgin Galactic’s sales growth is 39.5% for the current quarter and 208.4% for the next.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Virgin Galactic’s EBITDA is 27.93.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 21.8% and 25.5%, respectively.
Revenue Growth
Year-on-year quarterly revenue growth grew by 125.3%, now sitting on 4.86M for the twelve trailing months.
More news about Virgin Galactic.
Losers Today
1. NASDAQ TEST STOCK (ZVZZT) – -75.14%
NASDAQ ended the session with NASDAQ TEST STOCK falling 75.14% to $15.48 on Tuesday, after five successive sessions in a row of losses. NASDAQ fell 0.22% to $13,767.74, following the last session’s upward trend on what was a somewhat bearish trend trading session today.
Yearly Top and Bottom Value
NASDAQ TEST STOCK’s stock is valued at $15.48 at 01:32 EST, way under its 52-week high of $24.50 and way above its 52-week low of $12.05.
More news about NASDAQ TEST STOCK.
2. Aspen Group (ASPU) – -9.49%
Aspen Group, Inc., an education technology company, provides online higher education services in the United States. The company offers baccalaureate, master's, and doctoral degree programs in nursing and health sciences, business and technology, arts and sciences, and education fields through Aspen University and United States University. As of April 30, 2022, it had 13,334 degree-seeking students enrolled. Aspen Group, Inc. was founded in 1987 and is based in New York, New York.
NASDAQ ended the session with Aspen Group sliding 9.49% to $0.15 on Tuesday, following the last session’s downward trend. NASDAQ slid 0.22% to $13,767.74, following the last session’s upward trend on what was a somewhat down trend exchanging session today.
Earnings Per Share
As for profitability, Aspen Group has a trailing twelve months EPS of $-0.38.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -24.26%.
Sales Growth
Aspen Group’s sales growth is negative 24% for the ongoing quarter and negative 29.3% for the next.
More news about Aspen Group.
3. Kodak (KODK) – -8.44%
Eastman Kodak Company provides hardware, software, consumables, and services to customers in the commercial print, packaging, publishing, manufacturing, and entertainment markets worldwide. The company operates through four segments: Traditional Printing, Digital Printing, Advanced Materials and Chemicals, and Brand. The Traditional Printing segment offers digital offset plate and computer-to-plate imaging solutions to commercial industries, including commercial print, direct mail, book publishing, newspapers and magazines, and packaging. The Digital Printing segment provides electrophotographic printing solutions, such as The ASCEND and NEXFINITY printers; prosper products, including the PROSPER 6000 Press, PROSPER Writing Systems, PROSPER press systems, and PROSPER components; versamark products; and PRINERGY workflow production software. The Advanced Materials and Chemicals segment engages in industrial film and chemicals, motion picture, and advanced materials and functional printing businesses. This segment also comprises the Kodak Research Laboratories, which conducts research, develops new product or new business opportunities, and files patent applications for its inventions and innovations, as well as manages licensing of its intellectual property to third parties. The Brand segment engages in the licensing of Kodak brand to third parties. The company engages in the operation of Eastman Business Park, a technology center and industrial complex. It sells its products and services through direct sales, third party resellers, dealers, channel partners, and distributors. Eastman Kodak Company was founded in 1880 and is headquartered in Rochester, New York.
NYSE ended the session with Kodak sliding 8.44% to $3.47 on Tuesday, after two sequential sessions in a row of gains. NYSE rose 0.07% to $15,399.82, following the last session’s upward trend on what was a somewhat bullish trend exchanging session today.
Earnings Per Share
As for profitability, Kodak has a trailing twelve months EPS of $0.69.
PE Ratio
Kodak has a trailing twelve months price to earnings ratio of 5.03. Meaning, the purchaser of the share is investing $5.03 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.79%.
Yearly Top and Bottom Value
Kodak’s stock is valued at $3.47 at 01:32 EST, way under its 52-week high of $6.34 and way higher than its 52-week low of $2.78.
Moving Average
Kodak’s value is way under its 50-day moving average of $4.01 and way below its 200-day moving average of $4.26.
Volatility
Kodak’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.62%, a negative 0.20%, and a positive 2.03%.
Kodak’s highest amplitude of average volatility was 1.70% (last week), 2.31% (last month), and 2.03% (last quarter).
More news about Kodak.
4. BP Prudhoe Bay Royalty Trust (BPT) – -7.65%
BP Prudhoe Bay Royalty Trust operates as a grantor trust in the United States. The company holds overriding royalty interest in the Prudhoe Bay oil field located on the North Slope of Alaska. The Prudhoe Bay field extends approximately 12 miles by 27 miles and contains approximately 150,000 gross productive acres. BP Prudhoe Bay Royalty Trust was founded in 1989 and is based in Houston, Texas.
NYSE ended the session with BP Prudhoe Bay Royalty Trust dropping 7.65% to $3.26 on Tuesday, after five consecutive sessions in a row of losses. NYSE jumped 0.07% to $15,399.82, following the last session’s upward trend on what was a somewhat up trend trading session today.
Earnings Per Share
As for profitability, BP Prudhoe Bay Royalty Trust has a trailing twelve months EPS of $2.41.
PE Ratio
BP Prudhoe Bay Royalty Trust has a trailing twelve months price to earnings ratio of 1.35. Meaning, the purchaser of the share is investing $1.35 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 912.93%.
Moving Average
BP Prudhoe Bay Royalty Trust’s value is way below its 50-day moving average of $5.80 and way below its 200-day moving average of $6.91.
Revenue Growth
Year-on-year quarterly revenue growth declined by 99.4%, now sitting on 52.52M for the twelve trailing months.
Earnings Before Interest, Taxes, Depreciation, and Amortization
BP Prudhoe Bay Royalty Trust’s EBITDA is -155.91.
Volume
Today’s last reported volume for BP Prudhoe Bay Royalty Trust is 268674 which is 16.48% above its average volume of 230656.
More news about BP Prudhoe Bay Royalty Trust.
5. Xcel Brands (XELB) – -7.63%
Xcel Brands, Inc., together with its subsidiaries, operates as a media and consumer products company in the United States. The company designs, produces, licenses, markets, and sells branded apparel, footwear, accessories, jewelry, home goods, and other consumer products; and acquires consumer lifestyle brands, including the Isaac Mizrahi, the Judith Ripka, the H Halston, the Halston Heritage, and the C Wonder brands. It licenses its brands to third parties; and provides design, production, and marketing services for promotion and distribution through a ubiquitous-channel retail sales strategy, including distribution through interactive television, the Internet, and traditional brick-and-mortar retail channels. The company also offers social media marketing and other marketing, and public relations support for its brands. In addition, it markets the Mizrahi brands through isaacmizrahi.com; the Halston Brand through halston.com; the Judith Ripka Fine Jewelry brand through judithripka.com; and the C Wonder brands through cwonder.com. Xcel Brands, Inc. is headquartered in New York, New York.
NASDAQ ended the session with Xcel Brands dropping 7.63% to $0.86 on Tuesday while NASDAQ slid 0.22% to $13,767.74.
Earnings Per Share
As for profitability, Xcel Brands has a trailing twelve months EPS of $-0.97.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -28.9%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Xcel Brands’s EBITDA is -20.76.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Xcel Brands’s stock is considered to be overbought (>=80).
Moving Average
Xcel Brands’s value is way under its 50-day moving average of $1.08 and way below its 200-day moving average of $1.05.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Jan 1, 1970, the estimated forward annual dividend yield is 1.03%.
More news about Xcel Brands.
6. Everbridge (EVBG) – -6.67%
Everbridge, Inc. operates as a software company that enables customers to anticipate, mitigate, respond to, and recover from critical events in North America and internationally. The company offers Critical Event Management, a SaaS based platform, which offers various software applications for organizations for safeguarding business operations, people resilience, digital operations, smart security, and public safety. The Company's enterprise applications include Mass Notification, Safety Connection, IT Alerting, Visual Command Center, Public Warning, Community Engagement, Risk Center, Crisis Management, CareConverge, Control Center, 911 Connect, Travel Risk Management, SnapComms, and E911 for automating various critical event management processes. It serves enterprises, small businesses, non-profit organizations, educational institutions, and government agencies in technology, energy, financial services, healthcare and life sciences, manufacturing, media and entertainment, retail, higher education, and professional services industries. The company was formerly known as 3n Global, Inc. and changed its name to Everbridge, Inc. in April 2009. The company was founded in 2002 and is based in Burlington, Massachusetts.
NASDAQ ended the session with Everbridge falling 6.67% to $19.53 on Tuesday, following the last session’s upward trend. NASDAQ fell 0.22% to $13,767.74, following the last session’s upward trend on what was a somewhat bearish trend trading session today.
Earnings Per Share
As for profitability, Everbridge has a trailing twelve months EPS of $-0.68.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -4.36%.
More news about Everbridge.
7. Xeris Pharmaceuticals (XERS) – -6.65%
Xeris Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes ready-to-use injectable and infusible drug formulations. Its proprietary XeriSol and XeriJect formulation technology platforms allow for the subcutaneous and intramuscular delivery of highly-concentrated, ready-to-use formulations of peptides, small molecules, and proteins using commercially available syringes, auto-injectors, multi-dose pens, and infusion pumps. The company's lead product candidate is Gvoke HypoPen for the treatment of severe hypoglycemia, a potentially life-threatening condition in people with diabetes. Its product candidates also comprise ready-to-use glucagon that has completed Phase II clinical trials for the treatment of post-bariatric hypoglycemia, exercise-induced hypoglycemia in diabetes, bi-hormonal artificial pancreas closed-loop systems, congenital hyperinsulinism, and hypoglycemia-associated autonomic failure; and hypoglycemia associated with intermittent and chronic conditions. In addition, it develops ready-to-use diazepam formulation, which is in Phase Ib clinical trial for the treatment of Dravet syndrome and acute repetitive seizures in patients with epilepsy; and Pramlintide-Insulin co-formulation that is Phase II clinical trials for treating type 1 and 2 diabetes. Xeris Pharmaceuticals, Inc. serves patients, caregivers, and health practitioners. The company was founded in 2005 and is headquartered in Chicago, Illinois.
NASDAQ ended the session with Xeris Pharmaceuticals falling 6.65% to $1.68 on Tuesday, after two consecutive sessions in a row of losses. NASDAQ fell 0.22% to $13,767.74, following the last session’s upward trend on what was a somewhat bearish trend trading session today.
Earnings Per Share
As for profitability, Xeris Pharmaceuticals has a trailing twelve months EPS of $-0.46.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -209.81%.
Yearly Top and Bottom Value
Xeris Pharmaceuticals’s stock is valued at $1.68 at 01:32 EST, way under its 52-week high of $3.07 and way above its 52-week low of $0.97.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Xeris Pharmaceuticals’s EBITDA is -35.04.
Volume
Today’s last reported volume for Xeris Pharmaceuticals is 1544380 which is 61.24% above its average volume of 957779.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 25% and 20%, respectively.
More news about Xeris Pharmaceuticals.
8. Beyond Meat (BYND) – -6.58%
Beyond Meat, Inc. develops, manufactures, markets, and sells plant-based meat products in the United States and internationally. The company sells a range of plant-based meat products across the platforms of beef, pork, and poultry. It sells its products through grocery, mass merchandiser, club, convenience, and natural retailer channels, as well as various food-away-from-home channels, including restaurants, foodservice outlets, and schools. The company was formerly known as Savage River, Inc. and changed its name to Beyond Meat, Inc. in September 2018. Beyond Meat, Inc. was founded in 2009 and is headquartered in El Segundo, California.
NASDAQ ended the session with Beyond Meat dropping 6.58% to $6.45 on Tuesday, after two sequential sessions in a row of gains. NASDAQ fell 0.22% to $13,767.74, following the last session’s upward trend on what was a somewhat down trend trading session today.
Earnings Per Share
As for profitability, Beyond Meat has a trailing twelve months EPS of $-3.89.
Yearly Top and Bottom Value
Beyond Meat’s stock is valued at $6.45 at 01:32 EST, way below its 52-week high of $22.87 and way higher than its 52-week low of $5.58.
Moving Average
Beyond Meat’s worth is way below its 50-day moving average of $9.08 and way under its 200-day moving average of $13.21.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Beyond Meat’s stock is considered to be oversold (<=20).
More news about Beyond Meat.
9. Yield10 Bioscience (YTEN) – -5.46%
Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing disruptive technologies for step-changing improvements in crop yield in the United States and Canada. The company, through its Trait Factory, is involved in developing high value seed traits for the agriculture and food industries. It also has an oilseed development center in Saskatchewan, Canada. Yield10 Bioscience, Inc. has research agreements with Bayer AG to develop traits in soybean; Forage Genetics International, LLC to develop traits in forage sorghum; J. R. Simplot Company to develop novel traits in potato; and GDM Seeds Inc. to evaluate yield traits in soybeans. The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was founded in 1992 and is headquartered in Woburn, Massachusetts.
NASDAQ ended the session with Yield10 Bioscience sliding 5.46% to $0.22 on Tuesday, following the last session’s upward trend. NASDAQ slid 0.22% to $13,767.74, following the last session’s upward trend on what was a somewhat negative trend trading session today.
Earnings Per Share
As for profitability, Yield10 Bioscience has a trailing twelve months EPS of $-2.77.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -262.57%.
Moving Average
Yield10 Bioscience ‘s value is way under its 50-day moving average of $0.33 and way under its 200-day moving average of $1.93.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Yield10 Bioscience ‘s EBITDA is -3.99.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 45.1% and 61.2%, respectively.
Volume
Today’s last reported volume for Yield10 Bioscience is 137148 which is 45.02% below its average volume of 249471.
More news about Yield10 Bioscience .
10. Buenaventura Mining Company (BVN) – -5.38%
CompañÃa de Minas Buenaventura S.A.A., a precious metals company, engages in the exploration, mining, concentration, smelting, and marketing of polymetallic ores and metals in Peru, the United States, Europe, and Asia. It explores for gold, silver, lead, zinc, and copper metals. The company operates four operating mining units, including Uchucchacua, Orcopampa, Julcani, and Tambomayo in Peru; and San Gabriel, a mining unit under development stage. It also owns interests in Colquijirca, La Zanja, Yanacocha, Cerro Verde, El Brocal, Coimolache, Yumpaq, and San Gregorio mines, as well as Trapiche, a mining unit at the development stage. In addition, the company produces manganese sulphate, which is used in agriculture and mining industries. Further, it provides energy generation and transmission services through hydroelectric power plants; chemical processing services; insurance brokerage services; and industrial activities. The company was founded in 1953 and is based in Lima, Peru.
NYSE ended the session with Buenaventura Mining Company dropping 5.38% to $8.44 on Tuesday while NYSE jumped 0.07% to $15,399.82.
Earnings Per Share
As for profitability, Buenaventura Mining Company has a trailing twelve months EPS of $2.21.
PE Ratio
Buenaventura Mining Company has a trailing twelve months price to earnings ratio of 3.82. Meaning, the purchaser of the share is investing $3.82 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.15%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 8.1%, now sitting on 816.41M for the twelve trailing months.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Apr 20, 2023, the estimated forward annual dividend rate is 0.07 and the estimated forward annual dividend yield is 0.82%.
Yearly Top and Bottom Value
Buenaventura Mining Company’s stock is valued at $8.44 at 01:32 EST, under its 52-week high of $9.00 and way above its 52-week low of $6.45.
Moving Average
Buenaventura Mining Company’s worth is above its 50-day moving average of $8.40 and above its 200-day moving average of $7.84.
More news about Buenaventura Mining Company.
Stay up to date with our winners and losers daily report
